Manhattan Institute for Policy Research.
search  
 
Subscribe   Subscribe   MI on Facebook Find us on Twitter Find us on Instagram      
 
 
   
 
     
Andrew C. von Eschenbach.
HIGH-RES PHOTO
FOLLOW
ISSUES:
Medicare / Medicaid
Consumer-Driven Health Care
By von Eschenbach:
ARTICLES/OP-EDS
RESEARCH
CONTACT:
Katherine Lazarski,
Press Officer, Communications
646-839-3313
TOPICAL INDEX:
MI Publications &
City Journal Articles:
SCHOLARS INDEX:
Andrew von Eschenbach.

Andrew C. von Eschenbach, M.D. is chairman of the Manhattan Institute's Project FDA. From September of 2005 to January 2009 he served as commissioner of the U.S. Food and Drug Administration where he championed an agenda to modernize the FDA. Dr. von Eschenbach joined FDA after serving for four years as director of the National Cancer Institute (NCI) at the National Institutes of Health where he set an ambitious goal to eliminate the suffering and death due to cancer by rapid acceleration and integration of the discovery-development-delivery continuum. At the time of his appointment by President Bush to serve as director of NCI, he was president-elect of the American Cancer Society. Dr. von Eschenbach entered government service after over three decades as a physician, surgeon, oncologist, and executive that included numerous leadership roles from chairman of the department of urologic oncology to executive vice president and chief academic at the University of Texas M.D. Anderson Cancer Center in Houston. Author of more than 300 scientific articles and studies, Dr. von Eschenbach served as one of the founding members of the National Dialogue on Cancer. He has received numerous professional awards and honors. In 2006, Dr. von Eschenbach was named one of Time magazine's "100 most influential people to shape the world," and in both 2007 and 2008, he was selected as one of the Modern Healthcare/Modern Physician's "50 Most Powerful Physician Executives in Healthcare." Dr. von Eschenbach earned a B.S. from St. Joseph's University in his native Philadelphia and his medical degree from Georgetown University School of Medicine in Washington, D.C. He served as a Lt. Commander in the U.S. Navy Medical Corps. After completing a residency in urologic surgery at Pennsylvania Hospital in Philadelphia, he was an instructor in urology at the University of Pennsylvania School of Medicine. He completed a Fellowship in Urologic Oncology at the University of Texas M.D. Anderson Cancer Center.

He has been married to his childhood sweetheart, Madelyn, for over 40 years, and they are proud parents of four children and elated grandparents of seven.


[SORT BY CATEGORY] [SORT BY PUBLICATION TYPE]

Business and Economy
  • FDA Reform Can Lift U.S. Economy Bloomberg, 02-28-13


  • Economic Development
  • FDA Reform Can Lift U.S. Economy Bloomberg, 02-28-13


  • FDA Reform
  • Toward a 21st-Century FDA Wall Street Journal, 04-15-12
  • FDA Approvals Are a Matter of Life and Death Wall Street Journal, 06-17-12
  • FDA Reform Can Lift U.S. Economy Bloomberg, 02-28-13


  • Healthcare
  • Eliminating the Suffering and Death Due to Cancer by 2015 Medical Progress Bulletin, September 2005
  • Medical Innovation: How the U.S. Can Retain Its Lead Wall Street Journal, 02-14-12
  • Paul Howard interviews new Project FDA chairman, Dr. von Eschenbach about his Wall Street Journal op-ed, “Medical Innovation: How the U.S. Can Retain Its Lead.” Podcast: Interview, February 23, 2012
  • Paul Howard interviews Frmr FDA Commissioner Andrew von Eschenbach about post-market efficacy and the future of FDA. Podcast: Interview, February 23, 2012
  • FDA Reform Can Lift U.S. Economy Bloomberg, 02-28-13


  • National Politics
  • FDA Reform Can Lift U.S. Economy Bloomberg, 02-28-13


  • Value of Medicine
  • FDA Reform Can Lift U.S. Economy Bloomberg, 02-28-13


  •  

     

     
     
     

    The Manhattan Institute, a 501(c)(3), is a think tank whose mission is to develop and disseminate new ideas
    that foster greater economic choice and individual responsibility.

    Copyright © 2014 Manhattan Institute for Policy Research, Inc. All rights reserved.

    52 Vanderbilt Avenue, New York, N.Y. 10017
    phone (212) 599-7000 / fax (212) 599-3494